<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Diabetes: Urine Screening</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <h1 class="h1center">Diabetes: Urine Screening (NQF 0062)</h1>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Name</span></td>
               <td width="30%">Diabetes: Urine Screening</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Id</span></td>
               <td width="30%"> 2380012F-CEAA-4A65-B059-3185B338AA11</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Version number</span></td>
               <td width="30%">1</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Set Id</span></td>
               <td width="30%"> DE4053A5-C898-4A11-9DE2-E88A9CB65685</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Available Date</span></td>
               <td width="30%"> No information </td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td>January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">National Committee for Quality Assurance</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed by</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">The percentage of patients 18-75 years of age with diabetes (type 1 or type 2) who had a nephropathy screening test or evidence
                  of nephropathy.
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3"><pre>&copy; National Committee for Quality Assurance. All Rights Reserved</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Data Aggregation</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3"><pre>This measure assesses the percentage of patients in a specific age demographic who were diagnosed with type 1 or type 2 diabetes and who are susceptible to developing kidney disease as a comorbidity. Diabetes mellitus (diabetes) is a group of diseases characterized by high blood glucose levels caused by the body's inability to correctly produce or utilize the hormone insulin (NIDDK 2007). It is recognized as a leading cause of death and disability in the U.S. and is highly underreported as a cause of death (NIDDK 2007). Diabetes of either type may cause life-threatening, life-ending or life-altering complications, including end-stage kidney disease. Diabetes is the primary cause of kidney failure, accounting for 44% of newly diagnosed cases in 2005 (NIDDK 2007). Clinical guidelines recommend regular testing to evaluate urine albumin excretions and serum creatinine and the estimated glomerular filtration rate derived from serum creatinine, in addition to comparing measurements when screening for chronic kidney disease (ADA 2009; ACCE 2007). This measure facilitates the prevention and long-term management of kidney disease for patients diagnosed with diabetes.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3"><pre>American Diabetes Association (ADA), 2009:
. Perform an annual test to assess urine albumin excretion in type 1 diabetic patients with diabetes duration of &gt;=5 years and in all type 2 diabetic patients, starting at diagnosis. (E)
. Measure serum creatinine at least annually in all adults with diabetes regardless of the degree of urine albumin excretion. The serum creatinine should be used to estimate GFR and stage the level of chronic kidney disease (CKD), if present. (E)
. In the treatment of the nonpregnant patient with micro- or macroalbuminuria, either ACE inhibitors or ARBs should be used. (A)

American Association of Clinical Endocrinologists (AACE), 2007: Screen all patients with diabetes mellitus for chronic kidney disease annually; screening should begin 5 years after diagnosis in patients with T1DM and at the time of diagnosis in patients with T2DM. Testing includes:
- Measurement of albumin-to-creatinine ratio in a spot urine specimen and measurement of the estimated glomerular filtration rate derived from serum creatinine
- The following are diagnostic criteria for chronic kidney disease:
. Estimated glomerular filtration rate &lt;60 mL/min/1.73 m2 or albumin-to-creatinine ratio &gt;=30 mg albumin/g creatinine
. Microalbuminuria &gt;=30 mg albumin/g creatinine
. Macroalbuminuria &gt;=300 mg albumin/g creatinine (Grade A)
. Prescribe an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker in the antihypertensive regimen in the absence of contraindications. (Grade A)

American Geriatrics Society (AGS), 2003:  A test for the presence of microalbumin should be performed at diagnosis in patients with type 2 diabetes mellitus.  After the initial screening and in the absence of previously demonstrated macro- or microalbuminuria, a test for the presence of microalbumin should be performed annually. (Level III, Grade A)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement notation</span></td>
               <td width="80%" colspan="3"><pre>Higher score indicates better quality</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement duration</span></td>
               <td width="80%" colspan="3"><pre>24 month(s)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>American Association of Clinical Endocrinologists and American College of Endocrinology. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management 2002.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>American Diabetes Association: Clinical Practice Recommendations 2004. Hypertension Management in Adults with Diabetes (Position Statement). Diabetes Care. 2004;27 (suppl 1):65-67.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>California Healthcare Foundation/American Geriatrics Society (AGS) Improving Care of Elders with Diabetes. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. J Am Geriatr Soc 2003;51:S265-S280. Available at http://ww.americangeriatrics.org/education/diabetes_executive_summary.shtml Accessed September 2004.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Initial Patient Population(s): All patients 18 to 75 years of age during the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator(s): Patients in the initial population with a diagnosis of diabetes and at least 2 non-acute inpatient or outpatient encounters, or currently receiving medications indicative of diabetes during the measurement period or in the 12 months prior to the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exclusion(s): Patients with a diagnosis of polycystic ovaries, gestational diabetes or steroid-induced diabetes who did not have any face-to-face encounters in any setting, with a diagnosis of diabetes, during the measurement period or the 12 months prior to the measurement period</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Numerator(s): 
The number of patients who had a nephropathy screening test or evidence of nephropathy during the measurement year.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exception(s): N/A</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3"><pre>Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".</pre></td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d91049e372">Population criteria</a></li>
         <li><a href="#d91049e1818">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d91049e2483">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d91049e372" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic: birth date"  &gt;= 17 year(s) starts before start of "Measurement period"</li>
                  <li>AND: "Patient Characteristic: birth date"  &lt;= 74 year(s) starts before start of "Measurement period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Medication, Dispensed: Medications indicative of diabetes"</li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Diagnosis, Active: diabetes"</li>
                              <li>AND: 
                                 <ul>
                                    <li>OR: "Encounter: Encounter acute inpatient or ED"</li>
                                    <li>OR: 
                                       <ul>
                                          <li>AND: Count &gt;= 2  of:"Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"</li>
                                          <li>AND: FIRST:"Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"  &gt;= 1 day(s) starts before start of SECOND
                                             :"Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"
                                          </li>
                                       </ul>
                                       
                                    </li>
                                 </ul>
                                 
                              </li>
                           </ul>
                           
                        </li>
                        <li>  &lt;= 2 year(s) starts before or during "Measurement end date"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>AND: 
                                 <ul>
                                    <li>AND NOT: "Diagnosis, Active: diabetes"</li>
                                    <li>AND NOT: 
                                       <ul>
                                          <li>OR: "Encounter: Encounter acute inpatient or ED"</li>
                                          <li>OR: "Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"</li>
                                       </ul>
                                       
                                    </li>
                                    <li>  &lt;= 2 year(s) starts before or during "Measurement end date"</li>
                                 </ul>
                                 
                              </li>
                              <li>AND: "Diagnosis, Active: polycystic ovaries" starts before or during "Measurement end date"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND: 
                                 <ul>
                                    <li>OR: "Diagnosis, Active: gestational diabetes"</li>
                                    <li>OR: "Diagnosis, Active: steroid induced diabetes"</li>
                                 </ul>
                                 
                              </li>
                              <li>AND: 
                                 <ul>
                                    <li>OR: "Medication, Order: Medications indicative of diabetes"</li>
                                    <li>OR: "Medication, Dispensed: Medications indicative of diabetes"</li>
                                    <li>OR: "Medication, Active: Medications indicative of diabetes"</li>
                                 </ul>
                                 
                              </li>
                              <li>AND: 
                                 <ul>
                                    <li>AND NOT: "Diagnosis, Active: diabetes"</li>
                                    <li>AND NOT: 
                                       <ul>
                                          <li>OR: "Encounter: Encounter acute inpatient or ED"</li>
                                          <li>OR: "Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology"</li>
                                       </ul>
                                       
                                    </li>
                                 </ul>
                                 
                              </li>
                              <li>  &lt;= 2 year(s) starts before or during "Measurement end date"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Procedure, Performed: nephropathy-related procedures"</li>
                        <li>OR: "Diagnosis, Active: nephropathy"</li>
                        <li>OR: "Laboratory Test, Performed: nephropathy screening"</li>
                        <li>OR: "Laboratory Test, Performed: urine macroalbumin"</li>
                        <li>OR: "Medication, Order: ACE Inhibitors/ARBs"</li>
                        <li>OR: "Medication, Dispensed: ACE Inhibitors/ARBs"</li>
                        <li>OR: "Medication, Active: ACE Inhibitors/ARBs"</li>
                        <li> during "Measurement period"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d91049e1818" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: diabetes" using "diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.37)"
            </li>
            <li>
               "Diagnosis, Active: gestational diabetes" using "gestational diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.67)"
            </li>
            <li>
               "Diagnosis, Active: nephropathy" using "nephropathy Value Set GROUPING (2.16.840.1.113883.3.464.0001.343)"
            </li>
            <li>
               "Diagnosis, Active: polycystic ovaries" using "polycystic ovaries Value Set GROUPING (2.16.840.1.113883.3.464.0001.98)"
            </li>
            <li>
               "Diagnosis, Active: steroid induced diabetes" using "steroid induced diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.113)"
            </li>
            <li>
               "Encounter: Encounter acute inpatient or ED" using "Encounter acute inpatient or ED Value Set GROUPING (2.16.840.1.113883.3.464.0001.42)"
            </li>
            <li>
               "Encounter: Encounter non-acute inpatient, outpatient, or ophthalmology" using "Encounter non-acute inpatient, outpatient, or ophthalmology Value Set GROUPING (2.16.840.1.113883.3.464.0001.47)"
            </li>
            <li>
               "Laboratory Test, Performed: nephropathy screening" using "nephropathy screening Value Set GROUPING (2.16.840.1.113883.3.464.0001.348)"
            </li>
            <li>
               "Laboratory Test, Performed: urine macroalbumin" using "urine macroalbumin Value Set GROUPING (2.16.840.1.113883.3.464.0001.416)"
            </li>
            <li>
               "Medication, Active: ACE Inhibitors/ARBs" using "ACE Inhibitors/ARBs Value Set GROUPING (2.16.840.1.113883.3.464.0001.145)"
            </li>
            <li>
               "Medication, Active: Medications indicative of diabetes" using "Medications indicative of diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.94)"
            </li>
            <li>
               "Medication, Dispensed: ACE Inhibitors/ARBs" using "ACE Inhibitors/ARBs Value Set GROUPING (2.16.840.1.113883.3.464.0001.145)"
            </li>
            <li>
               "Medication, Dispensed: Medications indicative of diabetes" using "Medications indicative of diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.94)"
            </li>
            <li>
               "Medication, Order: ACE Inhibitors/ARBs" using "ACE Inhibitors/ARBs Value Set GROUPING (2.16.840.1.113883.3.464.0001.145)"
            </li>
            <li>
               "Medication, Order: Medications indicative of diabetes" using "Medications indicative of diabetes Value Set GROUPING (2.16.840.1.113883.3.464.0001.94)"
            </li>
            <li>
               "Patient Characteristic: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               "Procedure, Performed: nephropathy-related procedures" using "nephropathy-related procedures Value Set GROUPING (2.16.840.1.113883.3.464.0001.352)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d91049e2483" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>"Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"</li>
            <li>"Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"</li>
            <li>"Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"</li>
            <li>"Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)"</li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure set</span></td>
               <td colspan="3">CLINICAL QUALITY MEASURE SET 2011-2012</td>
            </tr>
         </tbody>
      </table>
   </body>
</html>